Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Comvita ( (NZ:CVT) ) just unveiled an announcement.
Comvita has disclosed that chair Bridget Coates and directors Robert Major and Michael Sang have all increased their holdings of ordinary shares through participation in the company’s recent renounceable entitlement offer. The trio acquired shares at NZ$0.65 each, lifting their respective stakes and signalling governance-level support for the capital raising as the business pursues its strategic objectives.
Coates’ beneficial interest rose from 45,000 to 82,802 shares, Major’s holding climbed from 53,510 to 88,483 shares, and Sang’s stake increased from 20,000 to 36,801 shares. The purchases, made outside any closed trading period under Comvita’s securities policy, modestly strengthen insider ownership and may be interpreted by investors as a vote of confidence in the company’s outlook and the expected use of the new equity.
More about Comvita
Comvita Limited is a New Zealand listed company best known for its production and sale of natural health products, notably mānuka honey and related bee-derived wellness goods. The group focuses on premium branded products for export markets, particularly in Asia, where demand for functional and immune-supporting foods has underpinned its growth strategy.
Average Trading Volume: 271,315
Technical Sentiment Signal: Sell
Current Market Cap: N$85.18M
For detailed information about CVT stock, go to TipRanks’ Stock Analysis page.